1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Global Generics, MarketLine

Global Generics, MarketLine

  • January 2016
  • -
  • MarketLine
  • -
  • 33 pages

Summary

Table of Contents

Search Inside

Introduction

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Global generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

- The global generics market is expected to generate total revenues of $271.2bn in 2015, representing a compound annual growth rate (CAGR) of 9% between 2011 and 2015.

- Market consumption volume is forecast to reach a total of 82.2% of total pharma volume in 2015.

- The onset of the global economic crisis has led to several countries strengthening their generic policies. These policies have contributed to the strong growth experienced in this market in recent years.

Features

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in the global

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalgenerics market

- Leading company profiles reveal details of key generics market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Global generics market with five year forecasts by both value and volume



Key Questions Answered

- What was the size of the Global generics market by value in 2015?

- What will be the size of the Global generics market in 2020?

- What factors are affecting the strength of competition in the Global generics market?

- How has the market performed over the last five years?

- How large is the global’s generics market in relation to its regional counterparts?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • April 2017
    44 pages
  • Therapy  

    Serotonin Speci...  

    Antidepressant  

  • United States  

View report >

Therapy Market and Monoclonal Antibody Market in the Netherlands

  • April 2017
    13 pages
  • Therapy  

    Monoclonal Anti...  

    Targeted Therap...  

  • Netherlands  

View report >

Stroke Statistics in the US

  • April 2017
    4 pages
  • Stroke  

    Blood Disease  

  • United States  

View report >

Related Market Segments :

Pharmaceutical

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.